Effect of gavaged chemical form of 241Am on its retention in mice.
The retention of 241Am in mice 48 h after administration by gavage is reported here. The 241Am was given to mice in the form of either 241Am nitrate or 241Am citrate. The 241Am was also injected into rats in the same form. The homogenized livers of those rats were subsequently administered by gavage to another group of mice. The retention of 241Am citrate was 1.5 X 10(-2)% of the original dose and was the highest among the compounds examined. The retention of biologically incorporated 241Am into the liver as 241Am nitrate and as 241Am citrate was 2.4 X 10(-3) and 2.6 X 10(-3)%, respectively, and was similar to the retention of 241Am nitrate, which was 2.8 X 10(-3)%. The ratio of the retention in the carcass to that in the liver for the 241Am citrate was lower than that of the 241Am nitrate and the biologically incorporated 241Am. This difference indicates that the distribution of 241Am in the animal body depends on the chemical form administered. The retention of liver-incorporated 241Am as citrate after autolysis of the liver is similar to that of fresh liver-incorporated 241Am citrate.
D000576:Americium / Q000378:metabolism*; D000818:Animals; D001329:Autolysis; D001822:Body Burden; D002951:Citrates / Q000378:metabolism*; D019343:Citric Acid; D005260:Female; D007408:Intestinal Absorption; D007441:Intubation, Gastrointestinal; D008099:Liver / Q000378:metabolism; D051379:Mice; D008813:Mice, Inbred ICR; D051381:Rats
D002951:Citrates; C041805:americium nitrate; D019343:Citric Acid; D000576:Americium